Ascendis Pharma Receives Positive CHMP Opinion for TransCon™ PTH (palopegteriparatide) for Adults with Chronic Hypoparathyroidism
Source:
Nasdaq GlobeNewswire
/
14 Sep 2023 12:22:57 America/New_York
N/A
Share on,